SCLCs dominantly expressing ASCL1 or NEUROD1 typically exhibit high levels of thyroid transcription factor-1 (TTF-1) and NE markers, comprising the majority of SCLC cases. This evidence concerns the gene NEUROD1 and small cell lung carcinoma.